Contact
searchSearch
HMP Global
Login

Obsessive-Compulsive and Related Disorders

Featured

John Grant, MD
Your Questions Answered
Distinguishing Visual Hallucinations, OCD Imagery, and Anxiety
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network
Mortality Risk May Be Higher in People With OCD
News
Mortality Risk May Be Higher in People With OCD
02/01/2024
Evi Arthur
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive...
02/01/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
News
Perseverative Behaviors Warrant Attention in Patients With Huntington Disease
12/28/2023
Jolynn Tumolo
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology
From Neurology
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Jolynn Tumolo
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network
Pop quiz!
Quiz
What is the duration of a “time-consuming” compulsion in OCD?
12/28/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/28/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
What percentage of patients with OCD have a lifetime tic disorder?
Quiz
What percentage of patients with OCD have a lifetime tic disorder?
08/23/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
08/23/2023
Psych Congress Network
Brain region graphic
News
TMS Shows Promise in Effective Obsessive-Compulsive Disorder Treatment
08/11/2023
Meagan Thistle
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and...
08/11/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
From Addiction Professional

Quizzes

Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network
Pop quiz!
Quiz
What is the duration of a “time-consuming” compulsion in OCD?
12/28/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/28/2023
Psych Congress Network
What percentage of patients with OCD have a lifetime tic disorder?
Quiz
What percentage of patients with OCD have a lifetime tic disorder?
08/23/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
08/23/2023
Psych Congress Network
Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Psilocybin Outcomes for MDD
06/11/2026
Brionna Mendoza
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
06/11/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
Nishi Bhopal, MD
Quiz
First Steps in Identifying Excessive Daytime Sleepiness
05/06/2026
Maria Mantas
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first...
05/06/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network

News & Insights

John Grant, MD
Your Questions Answered
Distinguishing Visual Hallucinations, OCD Imagery, and Anxiety
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
Mortality Risk May Be Higher in People With OCD
News
Mortality Risk May Be Higher in People With OCD
02/01/2024
Evi Arthur
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive disorder (OCD) may have a higher risk of mortality, both all-cause and due to natural causes, than individuals without OCD, according to recent population-based cohort study results published in The BMJ.
People with obsessive-compulsive...
02/01/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
News
Perseverative Behaviors Warrant Attention in Patients With Huntington Disease
12/28/2023
Jolynn Tumolo
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Jolynn Tumolo
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
Brain region graphic
News
TMS Shows Promise in Effective Obsessive-Compulsive Disorder Treatment
08/11/2023
Meagan Thistle
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and meta-analysis published in the journal Life reveals promising results for using Transcranial Magnetic Stimulation (TMS) in treating obsessive-compulsive disorder (OCD).
A recent systematic review and...
08/11/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
News
FDA Clears Brainsway TMS as a Treatment for OCD
08/17/2018
The Brainsway Deep Transcranial Magnetic Stimulation (TMS) System can be marketed as a treatment for obsessive compulsive disorder (OCD), the US Food and Drug Administration (FDA) announced.
The Brainsway Deep Transcranial Magnetic Stimulation (TMS) System can be marketed as a treatment for obsessive compulsive disorder (OCD), the US Food and Drug Administration (FDA) announced.
The Brainsway Deep Transcranial...
08/17/2018
Psych Congress Network
a young woman lies awake in bed
News
Adolescent Insomnia and Daytime Sleepiness Linked to Depression Risk
06/25/2026
Maria Mantas
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study...
06/25/2026
Psych Congress Network
A man with depression holds his head in his hands
Research Summary
Navacaprant Fails Late-Stage MDD Trials
06/22/2026
Brionna Mendoza
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid...
06/22/2026
Psych Congress Network
a man surrounded by alcohol and other substances on a table
News
Reduced Stimulant Use Outcomes May Reveal Treatment Effects Missed by Abstinence Measures
06/18/2026
Maria Mantas
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use...
06/18/2026
Psych Congress Network
Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
a woman scrolls on her phone while laying in bed
News
US Study Finds No Link Between AI Use and Depression
05/28/2026
Maria Mantas
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation...
05/28/2026
Psych Congress Network
A clinician in the lab pulls a psilocybin mushroom from a bag using tweezers major depressive disorder mdd treatment
News
Single-Dose Psilocybin Rapidly Improves MDD Symptoms, RCT Finds
05/19/2026
Brionna Mendoza
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was...
05/19/2026
Psych Congress Network
injection for schizophrenia treatment
News
Once-Monthly Aripiprazole Demonstrates Favorable Benefit–Risk Profile in Schizophrenia Treatment
05/14/2026
Maria Mantas
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg...
05/14/2026
Psych Congress Network
Jain, Mattingly, and Raison
Rapid Reaction
Rapid Reactions: Psych Congress Faculty Respond to HHS Deprescribing Initiative
05/12/2026
Rakesh Jain, MD, MPH, RD; Greg Mattingly, MD; Charles L. Raison, MD
Psych Congress faculty members share their expert perspectives on the HHS deprescribing action plan and Dear Colleague letter.
Psych Congress faculty members share their expert perspectives on the HHS deprescribing action plan and Dear Colleague letter.
Psych Congress faculty members...
05/12/2026
Psych Congress Network
A man with depression holds his head in his hands
News
Lumateperone Tops Efficacy in Adjunctive Treatment for MDD, Review Finds
05/12/2026
Brionna Mendoza
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and...
05/12/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use